(3S)-1-(2,2-Difluoroethyl)pyrrolidin-3-ol, 95%, 50mg

Fmoc-(S)-3-Amino-4-(4-nitro-phenyl)-butyric acid, 97%, 250mg

4-Bromo-2-methylphenol, 97.0%, 5g

tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride, 98+%, 5g

Safety canisters with screw cap and UN-X approval, 5 l, 05KT, 1 Piece

5-((methylamino)methyl)pyridin-2(1H)-one dihydrobromide, 95.0%, 250mg

4-Hydrazinebenzoic acid, min. 97%, for synthesis, 100 g, glass packaging

Pyrene (purified by sublimation)>98.0%(GC)1g

4-benzyl-3-(2-fluorophenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

3-Acetyl-1,6-naphthyridin-2(1H)-one, 95.0%, 100mg

1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate, 95%, 1g

2-Hydroxyisonicotinonitrile, 95.0%, 25g

Imino(methyl)(4-(trifluoromethyl)phenyl)-l6-sulfanone, 100mg